Quick Answer
SI-BONE, Inc. reported Research And Development Expense of $17.45 million for the year ending 2025.
- SI-BONE, Inc. showed an increase of +5.4% in Research And Development Expense from 2024 to 2025.
- This data is from SI-BONE, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $1.47 million | Q1 2018: $1.21 million | Q2 2018: $1.30 million | Q3 2018: $1.37 million | Q1 2019: $1.68 million | Q2 2019: $1.95 million | Q3 2019: $1.87 million | Q1 2020: $2.09 million | Q2 2020: $2.17 million | Q3 2020: $2.78 million | Q1 2021: $2.96 million | Q2 2021: $3.15 million | Q3 2021: $3.29 million | Q1 2022: $3.58 million | Q2 2022: $3.48 million | Q3 2022: $3.09 million | Q1 2023: $3.29 million | Q2 2023: $3.66 million | Q3 2023: $3.92 million | Q1 2024: $4.35 million | Q2 2024: $4.35 million | Q3 2024: $3.99 million | Q1 2025: $4.53 million | Q2 2025: $4.31 million | Q3 2025: $4.24 million.
- Over the full 9 years of available data (2017 to 2025), SI-BONE, Inc.'s Research And Development Expense has grown by 216.5%.
- Historical annual values: Fiscal year 2025: $17.45 million | Fiscal year 2024: $16.56 million | Fiscal year 2023: $15.03 million | Fiscal year 2022: $13.63 million | Fiscal year 2021: $12.44 million | Fiscal year 2020: $9.46 million | Fiscal year 2019: $7.28 million | Fiscal year 2018: $5.38 million | Fiscal year 2017: $5.51 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: